Sale!

POMGNT1 Gene Muscular Dystrophy-Dystroglycanopathy Limb-Girdle Type C3 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The POMGNT1 gene muscular dystrophy-dystroglycanopathy limb-girdle type C3 (LGMD2O) genetic test is a specialized diagnostic procedure aimed at identifying mutations in the POMGNT1 gene, which are known to cause a specific form of muscular dystrophy. This condition is characterized by progressive weakness and wasting of the muscles around the shoulders, hips, and thighs, typically known as limb-girdle muscular dystrophy. The test is crucial for confirming the diagnosis, understanding the disease progression, and making informed decisions about treatment and management.

Performed at DNA Labs UAE, the test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any genetic abnormalities in the POMGNT1 gene. The cost of the test is 4400 AED, reflecting the specialized nature of the genetic analysis and the expertise required to interpret the results.

By identifying the specific mutations in the POMGNT1 gene, this genetic test enables personalized treatment plans and helps in predicting the course of the disease. It also provides essential information for family planning and the assessment of the risk of passing the condition on to future generations. DNA Labs UAE offers comprehensive support and guidance throughout the testing process, ensuring patients and their families receive the necessary information and care.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

POMGNT1 Gene Muscular dystrophy-dystroglycanopathy limb-girdle type C3 Genetic Test

At DNA Labs UAE, we offer the POMGNT1 Gene Muscular dystrophy-dystroglycanopathy limb-girdle type C3 Genetic Test. This test is designed to diagnose and provide information about a specific type of muscular dystrophy called muscular dystrophy-dystroglycanopathy (limb-girdle), type C3.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Before undergoing the POMGNT1 Gene Muscular dystrophy-dystroglycanopathy (limb-girdle), type C3 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with POMGNT1 Gene Muscular dystrophy-dystroglycanopathy (limb-girdle), type C3.

Test Details

The POMGNT1 gene is associated with muscular dystrophy-dystroglycanopathy (limb-girdle), type C3. This genetic disorder is characterized by muscle weakness and wasting, primarily in the muscles of the shoulders, upper arms, hips, and thighs. The condition is caused by mutations in the POMGNT1 gene, which plays a role in the production of a protein called O-mannosyltransferase 1.

NGS (Next-Generation Sequencing) genetic testing is utilized for the analysis of multiple genes or even the entire genome. In the case of POMGNT1 gene testing, NGS can identify mutations or variations in the POMGNT1 gene that may contribute to the development of muscular dystrophy-dystroglycanopathy (limb-girdle), type C3. This type of genetic testing aids in the diagnosis of the condition and provides information about the risk of passing it on to future generations.

It is important to note that genetic testing should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support.

Test Name POMGNT1 Gene Muscular dystrophy-dystroglycanopathy limb-girdle type C3 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for POMGNT1 Gene Muscular dystrophy-dystroglycanopathy (limb-girdle), type C3 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with POMGNT1 Gene Muscular dystrophy-dystroglycanopathy (limb-girdle), type C3
Test Details

The POMGNT1 gene is associated with a specific type of muscular dystrophy called muscular dystrophy-dystroglycanopathy (limb-girdle), type C3. This genetic disorder is characterized by muscle weakness and wasting, particularly in the muscles of the shoulders, upper arms, hips, and thighs. It is caused by mutations in the POMGNT1 gene, which is involved in the production of a protein called O-mannosyltransferase 1.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes or even the entire genome. In the case of POMGNT1 gene testing, NGS can be used to identify mutations or variations in the POMGNT1 gene that may be responsible for the development of muscular dystrophy-dystroglycanopathy (limb-girdle), type C3. This type of genetic testing can help in the diagnosis of the condition and provide information about the risk of passing it on to future generations.

It is important to note that genetic testing should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support.